Results 101 to 110 of about 272 (120)
Some of the next articles are maybe not open access.

mTOR: from growth signal integration to cancer, diabetes and ageing

Nature Reviews Molecular Cell Biology, 2010
Roberto Zoncu   +2 more
exaly  

Engineering immunomodulatory biomaterials for type 1 diabetes

Nature Reviews Materials, 2019
Cherie L Stabler, Ying Li
exaly  

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Nature Reviews Clinical Oncology, 2016
Adi J Klil-Drori   +2 more
exaly  

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

New England Journal of Medicine, 2005
John M Lachin, Bernard Zinman Cm
exaly  

ANDROGEN DEPRIVATION RAISES RISK OF DIABETES, HEART DISEASE

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Steven P Marso   +2 more
exaly  

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2019
Vlado Perkovic   +2 more
exaly  

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
Itamar Raz, Marc P Bonaca, Ofri Mosenzon
exaly  

Home - About - Disclaimer - Privacy